Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Chomyszyn-Gajewska M [Evaluation of chosen salivary periodontal disease markers]. 2010 Prz. Lek. pmid:20687387
Thiele T et al. [Heparin-induced thrombocytopenia]. 2010 Internist (Berl) pmid:20694716
Jiang P et al. PMS-1077, a PAF antagonist, induced differentiation of HL-60 cells with its novel activity. 2010 Cell Biol. Int. pmid:20812915
Renteria LS et al. Prolonged hypoxia modulates platelet activating factor receptor-mediated responses by fetal ovine pulmonary vascular smooth muscle cells. 2010 Mol. Genet. Metab. pmid:20813571
Church MK Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males. 2010 Br. J. Dermatol. pmid:20819087
Hasan AM et al. Phosphoinositide 3-kinase gamma mediates chemotactic responses of human eosinophils to platelet-activating factor. 2010 Int. Immunopharmacol. pmid:20685403
Zhao W et al. [Expression and regulation of pituitary adenylate cyclase-activating polypeptide mRNA in pregnant rat corpus luteum]. 2010 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21038678
Asaka N et al. Effects of the new benzimidazole derivative TAS-203, an orally active phosphodiesterase 4 inhibitor, on airway inflammation in rats and emetic responses in ferrets. 2010 Arzneimittelforschung pmid:21117500
Lin S et al. Abietane and C20-norabietane diterpenes from the stem bark of Fraxinus sieboldiana and their biological activities. 2010 J. Nat. Prod. pmid:20961093
He J et al. The induction of an angiogenic response in corneal myofibroblasts by platelet-activating factor (PAF). 2010 Curr. Eye Res. pmid:20961214
Rechka A et al. Identification of VEGF receptor-2 tyrosine phosphorylation sites involved in VEGF-mediated endothelial platelet-activating factor synthesis. 2010 Can. J. Physiol. Pharmacol. pmid:20962896
Soliman A et al. Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitis. 2010 PLoS ONE pmid:20976181
Gao F et al. [The levels of platelet-activating factor and nitric oxide synthase in bronchial asthma at high altitude]. 2010 Zhonghua Jie He He Hu Xi Za Zhi pmid:20979844
Xu CL et al. [Inhibitory effect of TBN on platelet aggregation in rabbit]. 2010 Zhong Yao Cai pmid:21243778
Zhu X et al. Effects of ropivacaine on adhesion molecule CD11b expression and function in human neutrophils. 2010 Int. Immunopharmacol. pmid:20348036
Zhao D et al. PAF exerts a direct apoptotic effect on the rat H9c2 cardiomyocytes in Ca2+-dependent manner. 2010 Int. J. Cardiol. pmid:19237210
Karantonis HC et al. Platelet-activating factor involvement in thioacetamide-induced experimental liver fibrosis and cirrhosis. 2010 Dig. Dis. Sci. pmid:19242794
Lefebvre JS et al. Toll-like receptor ligands induce polymorphonuclear leukocyte migration: key roles for leukotriene B4 and platelet-activating factor. 2010 FASEB J. pmid:19843712
Kida T et al. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models. 2010 Exp. Eye Res. pmid:20412793
Lorrain DS et al. Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation. 2010 Eur. J. Pharmacol. pmid:20519143
Salmon MD and Ahluwalia J Discrimination between receptor- and store-operated Ca(2+) influx in human neutrophils. 2010 Cell. Immunol. pmid:20716450
Chen S et al. [Induction effect of platelet-activating factor on Src-suppressed C kinase substrate gene expression in rat pulmonary microvascular endothelial cells]. 2010 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:20367900
Leoni G et al. The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature. 2010 Br. J. Pharmacol. pmid:20331604
Danker K et al. Glycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane. 2010 Br. J. Pharmacol. pmid:20331609
Kajiwara N et al. Activation of human mast cells through the platelet-activating factor receptor. 2010 J. Allergy Clin. Immunol. pmid:20392487
Corl CM et al. Lipoxygenase metabolites modulate vascular-derived platelet activating factor production following endotoxin challenge. 2010 Vet. Immunol. Immunopathol. pmid:20359754
Shi C et al. H2O2 and PAF mediate Abeta1-42-induced Ca2+ dyshomeostasis that is blocked by EGb761. 2010 Neurochem. Int. pmid:20362023
Coppo R et al. Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes. 2010 Kidney Int. pmid:20016469
Xu Z et al. Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor. 2010 Mol. Ther. pmid:19953082
Ma J et al. Signaling in TRPV1-induced platelet activating factor (PAF) in human esophageal epithelial cells. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19959817
Hasegawa S et al. Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain. 2010 PLoS ONE pmid:20454616
Yang L et al. Chronic alcohol exposure increases circulating bioactive oxidized phospholipids. 2010 J. Biol. Chem. pmid:20460374
Esquenazi S and Bazan HE Role of platelet-activating factor in cell death signaling in the cornea: A review. 2010 Mol. Neurobiol. pmid:20431963
Iyú D et al. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function. 2010 Platelets pmid:20433310
Denizot Y Platelet-activating factor and acute myelogenous leukemia. 2010 Exp. Hematol. pmid:20303379
Rieder F et al. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:20299604
Prokosch V et al. Alpha2-adrenergic receptors and their core involvement in the process of axonal growth in retinal explants. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20592227
Morimoto R et al. Phosphorylation of lysophosphatidylcholine acyltransferase 2 at Ser34 enhances platelet-activating factor production in endotoxin-stimulated macrophages. 2010 J. Biol. Chem. pmid:20663880
Balestrieri ML et al. Endothelial progenitor cells express PAF receptor and respond to PAF via Ca(2+)-dependent signaling. 2010 Biochim. Biophys. Acta pmid:20637897
Karasuyama H et al. Role for basophils in systemic anaphylaxis. 2010 Chem Immunol Allergy pmid:20519883
Sanz ML et al. In vitro diagnosis of anaphylaxis. 2010 Chem Immunol Allergy pmid:20519886
Sharma J et al. Endothelial cell prostaglandin I(2) and platelet-activating factor production are markedly attenuated in the calcium-independent phospholipase A(2)beta knockout mouse. 2010 Biochemistry pmid:20521843
Cerkiene Z et al. Immune factors in human embryo culture and their significance. 2010 Medicina (Kaunas) pmid:20571290
Adamson RH et al. Sphingosine-1-phosphate modulation of basal permeability and acute inflammatory responses in rat venular microvessels. 2010 Cardiovasc. Res. pmid:20542878
Zhou X and He P Endothelial [Ca2+]i and caveolin-1 antagonistically regulate eNOS activity and microvessel permeability in rat venules. 2010 Cardiovasc. Res. pmid:20080986
Kenchegowda S and Bazan HE Significance of lipid mediators in corneal injury and repair. 2010 J. Lipid Res. pmid:19965607
Jørgensen KM et al. Platelet activating factor stimulates arachidonic acid release in differentiated keratinocytes via arachidonyl non-selective phospholipase A2. 2010 Arch. Dermatol. Res. pmid:20041255
Coy Barrera ED and Cuca Suárez LE In vitro inhibitory activities of Lauraceae aporphine alkaloids. 2010 Nat Prod Commun pmid:20420312
Dyer KD et al. Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor. 2010 J. Immunol. pmid:20421642
Bate C et al. Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation. 2010 J. Biol. Chem. pmid:20427265
Shin SH et al. Platelet-activating factor receptor mediates oxidized low density lipoprotein-induced migration of bone marrow-derived mesenchymal stem cells. 2010 Cell. Physiol. Biochem. pmid:21063106
Mrówczyńska L and Hägerstrand H Platelet-activating factor interaction with the human erythrocyte membrane. 2009 Sep-Oct J. Biochem. Mol. Toxicol. pmid:19827129
Babayigit A et al. Effects of Ginkgo biloba on airway histology in a mouse model of chronic asthma. 2009 Mar-Apr Allergy Asthma Proc pmid:19118503
Mann O et al. Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity. 2009 Pancreas pmid:18695628
Yang HQ et al. PMS777, a new cholinesterase inhibitor with anti-platelet activated factor activity, regulates amyloid precursor protein processing in vitro. 2009 Neurochem. Res. pmid:18758955
Liu SH et al. [Effects of p38 mitogen-activated protein kinase in protection of carbon monoxide against lipopolysaccharide induced rat small intestine injury]. 2009 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21189571
Castro DP et al. Physalin B inhibits Rhodnius prolixus hemocyte phagocytosis and microaggregation by the activation of endogenous PAF-acetyl hydrolase activities. 2009 J. Insect Physiol. pmid:19232405
Yao Y et al. Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species. 2009 J. Immunol. pmid:19234179
Shindou H and Shimizu T [New development of lysophospholipid acyltransferases]. 2009 Tanpakushitsu Kakusan Koso pmid:19205351
Seki M et al. Expression and DNA microarray analysis of a platelet activating factor-related molecule in severe pneumonia in mice due to influenza virus and bacterial co-infection. 2009 Jpn. J. Infect. Dis. pmid:19168951
Schneider DJ and Sobel BE Streamlining the design of promising clinical trials: in-vitro testing of antithrombotic regimens and multiple agonists of platelet activation. 2009 Coron. Artery Dis. pmid:19194284
Li J et al. Protection of PMS777, a new AChE inhibitor with PAF antagonism, against amyloid-beta-induced neuronal apoptosis and neuroinflammation. 2009 Cell. Mol. Neurobiol. pmid:19194797
Fité-Mora R Torsade de pointes associated with rupatadine. 2009 Rev Esp Cardiol pmid:19268083
Kim DD et al. Independent regulation of periarteriolar and perivenular nitric oxide mechanisms in the in vivo hamster cheek pouch microvasculature. 2009 Microcirculation pmid:19235626
Eckels PC et al. Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils. 2009 Am. J. Physiol., Cell Physiol. pmid:19295175
Melnikova VO and Bar-Eli M Inflammation and melanoma metastasis. 2009 Pigment Cell Melanoma Res pmid:19368690
Sánchez FA et al. Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19342481
Marotta DM et al. Mechanisms underlying the nociceptive responses induced by platelet-activating factor (PAF) in the rat paw. 2009 Biochem. Pharmacol. pmid:19283893
Yost CC et al. Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. 2009 Blood pmid:19221037
Tsoupras AB et al. The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants. 2009 Infect Disord Drug Targets pmid:19689381
Cheng L et al. A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice. 2009 Am. J. Physiol. Endocrinol. Metab. pmid:19773578
Wijman CA Is platelet activity important in acute intracerebral hemorrhage? 2009 Neurocrit Care pmid:19714496
Baka S et al. Treatment of sperm with platelet-activating factor does not improve intrauterine insemination outcome in unselected cases of mild male factor infertility: a prospective double-blind randomized crossover study. 2009 Urology pmid:19716589
Bao GQ and Ju AZ [Signal pathways of eryptosis-review]. 2009 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:19698269
Shi B et al. [Influence of intensive insulin therapy on the intestinal microcirculatory dysfunction in rats with sepsis]. 2009 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:19695175
Rastogi P and McHowat J Inhibition of calcium-independent phospholipase A2 prevents inflammatory mediator production in pulmonary microvascular endothelium. 2009 Respir Physiol Neurobiol pmid:19059366
Wen J et al. Simultaneous determination of rupatadine and its metabolite desloratadine in human plasma by a sensitive LC-MS/MS method: application to the pharmacokinetic study in healthy Chinese volunteers. 2009 J Pharm Biomed Anal pmid:19059745
Rehse K et al. New 1H-pyrazole-4-carboxamides with antiplatelet activity. 2009 Arch. Pharm. (Weinheim) pmid:19051198
Knezevic II et al. Tiam1 and Rac1 are required for platelet-activating factor-induced endothelial junctional disassembly and increase in vascular permeability. 2009 J. Biol. Chem. pmid:19095647
Rigat B et al. GM2 activator protein inhibits platelet activating factor signaling in rats. 2009 Biochem. Biophys. Res. Commun. pmid:19486886
Liu SX et al. Platelet-activating factor induces the processing of nuclear factor-kappaB p105 into p50, which mediates acute bowel injury in mice. 2009 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19460845
Kovacova E et al. General changes in hemostasis in gastric cancer. 2009 Bratisl Lek Listy pmid:19507648
Sharif NA et al. Human conjunctival epithelial cell responses to platelet-activating factor (PAF): signal transduction and release of proinflammatory cytokines. 2009 Mol. Vis. pmid:19513187
Tang WZ et al. Rearranged prenylated C6-C3 compounds and a highly oxygenated seco-prezizaane-type sesquiterpene from the stem bark of Illicium oligandrum. 2009 J. Nat. Prod. pmid:19496609
Hakim-Rad K et al. Mast cells: makers and breakers of allergic inflammation. 2009 Curr Opin Allergy Clin Immunol pmid:19550301
Li Y et al. Activation of a chloride channel by a trophic ligand is required for development of the mouse preimplantation embryo in vitro. 2009 Biol. Reprod. pmid:19553604
Deng Y et al. Blood-brain barrier breakdown by PAF and protection by XQ-1H due to antagonism of PAF effects. 2009 Eur. J. Pharmacol. pmid:19555682
Edwards LJ and Constantinescu CS Platelet activating factor/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases. 2009 Inflamm Allergy Drug Targets pmid:19601878
Camerer E et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. 2009 J. Clin. Invest. pmid:19603543
Xu J et al. Platelet-activating factor-stimulated production of reactive oxygen species in ovarian granulosa cells from periovulatory follicles. 2009 Cytometry A pmid:19565634
Eggert D et al. Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders. 2009 J. Neuroimmunol. pmid:19541372
Coy ED et al. Macrophyllin-type bicyclo[3.2.1]octanoid neolignans from the leaves of Pleurothyrium cinereum. 2009 J. Nat. Prod. pmid:19548690
Coy-Barrera ED et al. PAF-antagonistic bicyclo[3.2.1]octanoid neolignans from leaves of Ocotea macrophylla Kunth. (Lauraceae). 2009 Phytochemistry pmid:19674762
Kordan W et al. Effect of platelet-activating factor on motility, plasmalemma integrity, the process of capacitation and acrosome reaction of fresh and cryopreserved boar spermatozoa. 2009 Pol J Vet Sci pmid:19645346
Poisson C et al. Caveolae facilitate but are not essential for platelet-activating factor-mediated calcium mobilization and extracellular signal-regulated kinase activation. 2009 J. Immunol. pmid:19620302
Jeong YI et al. The novel role of platelet-activating factor in protecting mice against lipopolysaccharide-induced endotoxic shock. 2009 PLoS ONE pmid:19652714
Keck M et al. Pathophysiology of burns. 2009 Wien Med Wochenschr pmid:19652939
Mayerle J A novel role for leucocytes in determining the severity of acute pancreatitis. 2009 Gut pmid:19834113
Pantaler E and Lückhoff A Inhibitors of TRP channels reveal stimulus-dependent differential activation of Ca2+ influx pathways in human neutrophil granulocytes. 2009 Naunyn Schmiedebergs Arch. Pharmacol. pmid:19894037
He YG et al. Functional analysis of platelet-activating factor in the retinal pigment epithelial cells and choroidal endothelial cells. 2009 Curr. Eye Res. pmid:19958112